JD Health Releases 65 New Drugs in First Half, Leading the Industry and Expanding Its Dominance as China's Largest Online Pharmacy

Stock News08-13

JD Health (06618) reported a total revenue of RMB 40.9 billion for the first half of 2026, marking a 15.9% year-on-year increase. Under the Non-IFRS metric, its operating profit reached RMB 3.5 billion, up 40.3% from the same period last year.

The company focuses on its supply chain as a core strength, driving synergies between its self-operated, third-party platform, and instant retail businesses. It continues to expand its professional product offerings and reinforce its self-operated advantages, while also building an open ecosystem to grow alongside brand partners and platform merchants.

During the reporting period, JD Health further solidified its leadership in the pharmaceutical supply chain by launching 65 new drugs, covering areas such as chronic metabolic diseases, dermatology, and oncology. This reinforces its position as the "first stop for new drug launches nationwide." Additionally, by integrating specialized medical services with its self-operated drug supply chain, the company has established a differentiated edge in fields like dermatology and introduced AI-powered diagnostic tools built on the "Jingyi Qianxun" large model.

Online medical insurance payments have now been implemented in 40 cities, with JD Health pharmacies operating over 450 locations across 10 cities, achieving improvements in both supply fulfillment and service quality. From new drug launches to precise services, JD Health is leveraging its pharmaceutical supply chain as a foundation to continuously strengthen its full-cycle health service system.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1108533739?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-13 16:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108533739","market":"other","top_or_hot":-1,"title":"JD Health Releases 65 New Drugs in First Half, Leading the Industry and Expanding Its Dominance as China's Largest Online Pharmacy","media":"Stock News","content":"<p><b>JD Health (06618)</b> reported a total revenue of RMB 40.9 billion for the first half of 2026, marking a 15.9% year-on-year increase. Under the Non-IFRS metric, its operating profit reached RMB 3.5 billion, up 40.3% from the same period last year.<br><br>The company focuses on its supply chain as a core strength, driving synergies between its self-operated, third-party platform, and instant retail businesses. It continues to expand its professional product offerings and reinforce its self-operated advantages, while also building an open ecosystem to grow alongside brand partners and platform merchants.<br><br>During the reporting period, <b>JD Health</b> further solidified its leadership in the pharmaceutical supply chain by launching 65 new drugs, covering areas such as chronic metabolic diseases, dermatology, and oncology. This reinforces its position as the \"first stop for new drug launches nationwide.\" Additionally, by integrating specialized medical services with its self-operated drug supply chain, the company has established a differentiated edge in fields like dermatology and introduced AI-powered diagnostic tools built on the \"Jingyi Qianxun\" large model.<br><br>Online medical insurance payments have now been implemented in 40 cities, with <b>JD Health</b> pharmacies operating over 450 locations across 10 cities, achieving improvements in both supply fulfillment and service quality. From new drug launches to precise services, <b>JD Health</b> is leveraging its pharmaceutical supply chain as a foundation to continuously strengthen its full-cycle health service system.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JD Health Releases 65 New Drugs in First Half, Leading the Industry and Expanding Its Dominance as China's Largest Online Pharmacy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJD Health Releases 65 New Drugs in First Half, Leading the Industry and Expanding Its Dominance as China's Largest Online Pharmacy\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-08-13 16:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>JD Health (06618)</b> reported a total revenue of RMB 40.9 billion for the first half of 2026, marking a 15.9% year-on-year increase. Under the Non-IFRS metric, its operating profit reached RMB 3.5 billion, up 40.3% from the same period last year.<br><br>The company focuses on its supply chain as a core strength, driving synergies between its self-operated, third-party platform, and instant retail businesses. It continues to expand its professional product offerings and reinforce its self-operated advantages, while also building an open ecosystem to grow alongside brand partners and platform merchants.<br><br>During the reporting period, <b>JD Health</b> further solidified its leadership in the pharmaceutical supply chain by launching 65 new drugs, covering areas such as chronic metabolic diseases, dermatology, and oncology. This reinforces its position as the \"first stop for new drug launches nationwide.\" Additionally, by integrating specialized medical services with its self-operated drug supply chain, the company has established a differentiated edge in fields like dermatology and introduced AI-powered diagnostic tools built on the \"Jingyi Qianxun\" large model.<br><br>Online medical insurance payments have now been implemented in 40 cities, with <b>JD Health</b> pharmacies operating over 450 locations across 10 cities, achieving improvements in both supply fulfillment and service quality. From new drug launches to precise services, <b>JD Health</b> is leveraging its pharmaceutical supply chain as a foundation to continuously strengthen its full-cycle health service system.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"86618","symbol_name":"京东健康-R","start_time":0,"source_url":"","article_id":"1108533739","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108533739","pubTimestamp":1786611139,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"JD Health (06618) reported a total revenue of RMB 40.9 billion for the first half of 2026, marking a 15.9% year-on-year increase. Under the Non-IFRS metric, its operating profit reached RMB 3.5...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"86618":"京东健康-R","159938":"医药","BK1571":"互联网医疗","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","BK1589":"北水核心资产","BK1515":"抗疫概念","09939":"开拓药业-B","BK1161":"生物科技","BK1583":"高瓴概念","SGXZ86797644.SGD":"MAYBANK ASIAN GROWTH AND INCOME-I \"A\" (SGDHDG) INC","BK1591":"就地过年概念","BK1574":"生物医药B类股","BK1142":"互联网与直销零售","BK1615":"港股-互联网","06618":"京东健康","LU0051755006.USD":"摩根大通中国A (dist)","BK1247":"药品零售","SGXZ62798434.SGD":"MAYBANK ASIAN GROWTH AND INCOME-I \"A\" (SGDHDG) ACC"},"translate_title":"京东健康上半年发布65款新药，行业领先，扩大中国最大网上药店霸主地位","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"86618":1,"159938":1,"09939":1,"06618":1},"content_text":"JD Health (06618) reported a total revenue of RMB 40.9 billion for the first half of 2026, marking a 15.9% year-on-year increase. Under the Non-IFRS metric, its operating profit reached RMB 3.5 billion, up 40.3% from the same period last year.The company focuses on its supply chain as a core strength, driving synergies between its self-operated, third-party platform, and instant retail businesses. It continues to expand its professional product offerings and reinforce its self-operated advantages, while also building an open ecosystem to grow alongside brand partners and platform merchants.During the reporting period, JD Health further solidified its leadership in the pharmaceutical supply chain by launching 65 new drugs, covering areas such as chronic metabolic diseases, dermatology, and oncology. This reinforces its position as the \"first stop for new drug launches nationwide.\" Additionally, by integrating specialized medical services with its self-operated drug supply chain, the company has established a differentiated edge in fields like dermatology and introduced AI-powered diagnostic tools built on the \"Jingyi Qianxun\" large model.Online medical insurance payments have now been implemented in 40 cities, with JD Health pharmacies operating over 450 locations across 10 cities, achieving improvements in both supply fulfillment and service quality. From new drug launches to precise services, JD Health is leveraging its pharmaceutical supply chain as a foundation to continuously strengthen its full-cycle health service system.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1108533739","isCrawlerRequest":true}